Home

ZimVie Inc. - Common Stock (ZIMV)

18.73
+0.00 (0.00%)
NASDAQ · Last Trade: Jul 25th, 9:35 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to ZimVie Inc. - Common Stock (ZIMV)

DePuy Synthes (Johnson & Johnson) JNJ +0.00

DePuy Synthes, a subsidiary of Johnson & Johnson, competes with ZimVie in the orthopedic and neuro products space. With its vast resources and global reach, DePuy Synthes has a significant advantage in terms of research capabilities and brand loyalty. They regularly invest heavily in marketing and development to expand their product lines and improve surgical outcomes. While ZimVie aims to offer innovative solutions tailored to specific surgical needs, the scale and depth of DePuy Synthes' product portfolio give it a leading position in the market.

Medtronic plc MDT +0.00

Medtronic operates across multiple therapeutic areas with a wide array of products, including spinal and orthopedic devices that compete directly with ZimVie's offerings. Their competitive advantage lies in their extensive experience in the medical device market, a broad portfolio that leverages technology for patient solutions, and a well-established global distribution network. While ZimVie targets specific orthopedic niches aiming for innovation, Medtronic's larger scope and resources can overshadow ZimVie's market efforts in many segments.

Smith & Nephew plc SNN +0.00

Smith & Nephew competes with ZimVie in the advanced wound management and orthopedic reconstruction markets. It offers a range of healthcare products and services that overlap with ZimVie's offerings, particularly in surgical devices and implants. Smith & Nephew has established a strong international market presence with diversified product lines that cater to varying surgical needs. While ZimVie has some innovative products focused on specific segments, Smith & Nephew's broader industry reach and established market presence can provide it with an advantage.

Stryker Corporation SYK +0.00

Stryker Corporation is another major player in the orthopedic and surgical equipment sectors, competing directly with ZimVie Inc. in various product categories, including implants, instruments, and surgical devices. Stryker's competitive advantage derives from its larger scale and extensive research and development capabilities, allowing for continuous innovation in product lines. Their strong distribution networks and effective marketing strategies help solidify their leadership position. ZimVie, while innovative, faces challenges in scaling its products globally compared to Stryker's established systems.

Zimmer Biomet Holdings, Inc. ZBH +0.00

Zimmer Biomet is one of the leading competitors of ZimVie Inc. in the musculoskeletal healthcare market, particularly in orthopedic devices. Both companies focus on innovative solutions for bone repair and joint replacements. Zimmer Biomet has a more established portfolio of products and a stronger global presence, giving it a competitive advantage in market penetration and brand recognition. While ZimVie focuses on specific niches within the orthopedic field aimed at personalized healthcare solutions, Zimmer Biomet's broader range of offerings helps it maintain a leading edge in the industry.